Add to ORKGThis is the protocol for a review and there is no abstract. The objectives are as follows: To determine whether alternative agents (e.g. artificial platelet substitutes, platelet-poor plasma, fibrinogen, rFVIIa, thrombopoietin mimetics) are as effective and safe as the use of platelet transfusions for the prevention of bleeding (prophylactic platelet transfusion) in patients with haematological disorders who are undergoing myelosuppressive chemotherapy or stem cell transplantation. Anti-fibrinolytics (lysine analogues) will not be included in this review because they have been the focus of another Cochrane review (Wardrop 2013)
Background Patients with haematological disorders are frequently at risk of severe or life-threaten...
This is the protocol for a review and there is no abstract. The objectives are as follows:To determi...
BACKGROUND: The effectiveness of platelet transfusions to prevent bleeding in patients with hematolo...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To deter...
Background Platelet transfusions are used in modern clinical practice to prevent and treat bleeding ...
Background: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
To compare the relative efficacy of different treatments for thrombocytopenia (artificial platelet s...
BACKGROUND: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
BACKGROUND: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
Background Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
This publication is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Syst...
This is the protocol for a review and there is no abstract. The objectives are as follows: To compar...
Background Patients with haematological disorders are frequently at risk of severe or life-threaten...
This is the protocol for a review and there is no abstract. The objectives are as follows:To determi...
BACKGROUND: The effectiveness of platelet transfusions to prevent bleeding in patients with hematolo...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To deter...
Background Platelet transfusions are used in modern clinical practice to prevent and treat bleeding ...
Background: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
To compare the relative efficacy of different treatments for thrombocytopenia (artificial platelet s...
BACKGROUND: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
BACKGROUND: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
Background Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
This publication is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Syst...
This is the protocol for a review and there is no abstract. The objectives are as follows: To compar...
Background Patients with haematological disorders are frequently at risk of severe or life-threaten...
This is the protocol for a review and there is no abstract. The objectives are as follows:To determi...
BACKGROUND: The effectiveness of platelet transfusions to prevent bleeding in patients with hematolo...